Kiromic BioPharma

(OTC) KRBP

Current PriceN/A

Market CapN/A

Since IPO (2020)-100%

5 Year-100%

1 Year-100%

1 Month+0%

Kiromic BioPharma Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

$26.98M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

KRBP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Kiromic BioPharma

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Pietro Bersani, CPA

Website

www.kiromic.com

Headquarters

Houston, TX 77054, US

KRBP Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

Return on Assets

-3%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$0.00

Operating Income

$23.77M

EBITDA

$23.77M

Operating Cash Flow

$19.46M

Capital Expenditure

$366.00K

Free Cash Flow

$19.82M

Cash & ST Invst.

$1.14M

Total Debt

$14.57M

Kiromic BioPharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2024YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$6.49M

-38.4%

EBITDA

$5.16M

-76.1%

Quarterly Fundamentals

Name

Q4 2024YOY CHG

Net Cash

$13.43M

-8.9%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$228.00K

-75.0%

Short Term Debt

$14.34M

-2.0%

Return on Assets

-3.15%

N/A

Return on Invested Capital

1.92%

N/A

Free Cash Flow

$3.68M

+33.4%

Operating Cash Flow

$3.65M

+32.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

HURATuHURA Biosciences, Inc.

HURATuHURA Biosciences, Inc.$2.35-6.37%

CSTFCuraScientific Corp

CSTFCuraScientific Corp$0.00+0.00%

LNDZFEvome Medical Technologies Inc.

LNDZFEvome Medical Technologies Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

FFord Motor Company

FFord Motor Company$13.52-0.07%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.45-0.07%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.35-0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.52+0.04%

SLESuper League Enterprise

SLESuper League Enterprise$6.22+0.53%

TLTiShares Trust - iShares 20+ Year Treasury Bond ETF

TLTiShares Trust - iShares 20+ Year Treasury Bond ETF$83.73-0.01%

NUNu Holdings

NUNu Holdings$12.21-0.06%

Questions About KRBP

What is the current price of Kiromic BioPharma?

Kiromic BioPharma is trading at N/A per share.

What is the 52-week range for Kiromic BioPharma?

Over the past 52 weeks, Kiromic BioPharma has traded between N/A and N/A.

How much debt does Kiromic BioPharma have?

As of the most recent reporting period, Kiromic BioPharma reported total debt of $14.57M.

How much cash does Kiromic BioPharma have on hand?

Kiromic BioPharma reported $1.79M in cash and cash equivalents in its most recent financial results.

What is Kiromic BioPharma’s dividend yield?

Kiromic BioPharma does not currently have a dividend yield.

Kiromic BioPharma

Kiromic BioPharma Financials at a Glance

KRBP News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Kiromic BioPharma

KRBP Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Kiromic BioPharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About KRBP

What is the current price of Kiromic BioPharma?

What is the 52-week range for Kiromic BioPharma?

How much debt does Kiromic BioPharma have?

How much cash does Kiromic BioPharma have on hand?

What is Kiromic BioPharma’s dividend yield?

Premium Investing Services